BeiGene regains rights for cancer drug after Novartis deal termination

In this article:

Sept 19 (Reuters) - BeiGene said on Tuesday it would regain rights to develop and manufacture its cancer drug after a deal termination with Novartis. (Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi Majumdar)

Advertisement